Trial intelligence / Profile preview

Topical betamethasone valerate after cryotherapy for skin warts

IRCT20170818035762N3Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Apr 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of betamethasone in verruca (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Post-cryotherapy inflammatory symptoms. Started Apr 2019; status: completed.

02

Drugs

betamethasone
03

Conditions

verruca

Beyond the preview

Go deeper on IRCT20170818035762N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170818035762N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call